Home | Welcome to Contract Pharma   
Last Updated Tuesday, June 2 2015

Print

Search Results for 'Inspections'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Contract Service Directory Companies

View All Companies »


Contract Service Directory Categories

View All Categories »


Search Results:

Published May 19, 2015
Will offer complete portfolio of solutions and services Read More »
Published May 13, 2015
Will deploy inspection and quality control solutions; framework established for co-development projects Read More »
Published April 23, 2015
Dako completes corrective actions following Warning Letter Read More »
Published March 24, 2015
Bangalore oral solids manufacturing facility complied with all FDA requirements Read More »
Published February 17, 2015
Sterile fill production facility found in accordance with regulatory requirements Read More »
Published February 9, 2015
Found to be compliant with cGMP principles and guidelines Read More »
Published February 2, 2015
Allows for expanded manufacturing and packaging services for U.S. market Read More »
Published January 28, 2015
To manufacture Amotosalen API for Cerus Read More »
Published January 20, 2015
Will produce immunotherapy for the treatment of melanoma Read More »
Published January 13, 2015
Bedford facility to manufacture commercial drug for U.S. distribution Read More »
Published January 12, 2015
New VAI classification permits FDA approval of new products Read More »
Published December 17, 2014
Site compliant with GMP but Form 483 notes three inspectional observations Read More »
Published September 4, 2014
Complies with the quality GMP & GDP standards Read More »
Published September 3, 2014
Will test commercial drug product for the European market Read More »
Published August 18, 2014
To manufacture API for branded commercial drug Read More »
Published August 5, 2014
Ireland facility gains pre-approval Read More »
Published July 22, 2014
Will produce NME for U.S. market Read More »
Published July 8, 2014
Gains certification by Belgium and EU authorities Read More »
Published July 8, 2014
Inspection covered quality system and lab facilities in Torrance, CA Read More »
Published June 26, 2014
Enables CTM services in more than 44 Asian countries Read More »
Published June 12, 2014
Will manufacture Phase IIb batches of Ovasave for Crohn’s trial Read More »
Published June 5, 2014
Will reinstate GMP certificate Read More »
Published May 21, 2014
Suzhou site successfully passes three GLP inspections Read More »
Published April 30, 2014
Analytical and stability testing, and CTM services deemed compliant Read More »
By Kristin Brooks
Published March 27, 2014
Areas of toxicity, mutagenicity, analytical and clinical chemistry testing in compliance Read More »
FDA Aseptic Inspections Will Focus on Process, FDA’s Friedman Says
Published March 27, 2014
At a PDA conference track at Interphex 2014, FDA’s Richard Friedman, Associate DirectorAssociate Director of FDA’s Office of Manufacturing and Product Quality at the Center for Drug Evaluation and Research’s Office of Compliance, discussed changes in the way FDA inspectors will review aseptic facilities. The emphasis now, he says, will be on day to day process operations and control. Read More »
By Kristin Brooks
Published February 11, 2014
Quality Control testing and release Read More »
By Gil Roth
Published February 5, 2014
First-year goals met Read More »
By Kristin Brooks
Published January 27, 2014
Demonstrates proficiency in the safe handling of potent APIs and compounds Read More »
By Kristin Brooks
Published January 24, 2014
Prohibits manufacture and sale of drug ingredients from Toansa plant Read More »
By Kristin Brooks
Published January 21, 2014
Gains approval of Control Testing Lab Read More »
By Gil Roth
Published January 8, 2014
No observations at Manchester, NH site following GMP/PAI visit Read More »
By Kristin Brooks
Published December 17, 2013
IA site GMP compliant, with no Form 483 observations Read More »
By Kristin Brooks
Published December 10, 2013
Expands handling capabilities to all pharmaceutically relevant classes Read More »
By Gil Roth
Published December 10, 2013
Spokane CMO facility cited by agency Read More »
Safebridge Talks Safety
By Gil Roth
Published December 3, 2013
John P. Farris of SafeBridge at AAPS 2013 Read More »
Published December 3, 2013
Expands R&D services after German inspection Read More »
Published December 3, 2013
Prepares for commercial launch of BTG’s Varithena Read More »
By Gil Roth
Published November 18, 2013
Combines microbio validation and screening with rapid detection platform Read More »
By Ed Silverman, Contributing Editor
Published November 13, 2013
Can FDA get tough? Read More »
Packaging Validation: E&L Detection
By Kurt L. Moyer and James R. Scull, NSF Health Sciences
Published November 13, 2013
Improve patient safety and avoid costly product-launch delays Read More »
Automating Labeling Processes
By Chitra Lele and Bindu Narang, Sciformix Corporation
Published November 13, 2013
A global business model to ensure compliance and accuracy in an increasingly complex environment Read More »
High Potency Regulations
By Stephanie Wilkins, PharmaConsult US, Inc.
Published November 13, 2013
Uncertainty remains in the quest to define certain products Read More »
Published November 5, 2013
Resolves all issues at Burlington facility Read More »
By Gil Roth
Published November 4, 2013
Packaging intended to reduce medication errors Read More »
Published October 22, 2013
Audits demonstrate custom manufacturing capabilities Read More »
Published October 21, 2013
Goedheijt and Douwstra to head operations and production Read More »
Published October 17, 2013
Becomes first lab in China to be CLIA-certified Read More »


Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On